Heart Rate as a Risk Factor for Cardiovascular Disease

Progress in Cardiovascular Diseases

Volumn 52, Issue 1, 2009, Pages 6-10

  Perret Guillaume, Christine ^a   Joly, Laure ^a,b   Benetos, Athanase ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

Author keywords

Cardiovascular; Elderly; Epidemiology; Heart rate; Risk

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; DRUG TARGETING; HEART DEATH; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

AGE FACTORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; METABOLIC SYNDROME X; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA;

EID: 67650141667     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.05.003     Document Type: Article

References (35)

1. Dyer A., Persky V., Stamler J., et al. Heart rate as a prognostic factor for coronary heart disease and mortality findings in three Chicago Epidemiological studies. Am J Epidemiol 112 (1980) 136-749
2. Jouven X., Desnos M., Guerot C., et al. Predicting sudden death in the population: the Paris Prospective Study 1. Circulation 99 (1999) 1978-1983
3. Benetos A., Rudnichi A., Thomas F., et al. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 33 (1999) 44-52
4. Palatini P., Casiglia E., Julius S., et al. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159 (1999) 585-592
5. Kristal-Boneh E., Silber H., Harari G., et al. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 21 (2000) 116-124
6. Palatini P., Benetos A., and Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug Therapy. Drugs 66 (2006) 133-144
7. Hozawa A., Ohkubo T., Kikuya M., et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 17 (2004) 1005-1010
8. Beere P.A., Glagov S., and Zarins C.K. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 226 (1984) 180-182
9. Bassiouny H.S., Zarins C.K., Kadowaki M.H., et al. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 19 (1994) 426-434
10. Albaladejo P., Carusi A., Apartian A., et al. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res 40 (2003) 320-328
11. Mircoli L., Mangoni A., Giannattasio C., et al. Heart rate dependent stiffening of large arteries in intact and sympathectomized rats. Hypertension 34 (1999) 598-602
12. Fox K., Ford I., Steg G., and on behalf of the BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 6736 (2008) 61170-61178
13. Palatini P., and Julius S. Heart rate and the cardiovascular risk. J Hypertens 15 (1997) 3-17
14. Benetos A., Thomas F., Bean K., et al. Resting heart rate in the elderly: a predictor of survival to 85 years of age. J Am Ger Soc 51 (2003) 284-285
15. Morcet J., Safar M., Thomas F., et al. Associations between heart rate and other risk factors in a large French population. J Hypertens 17 (1999) 1671-1676
16. Gillum R.F., Makuc D.M., and Feldman J.J. Pulse rate, coronary heart disease, and death; the NHANES I Epidemiologic Follow-Up Study. Am Heart J 121 (1991) 171-177
17. Levy R.L., White P.D., Strod W.D., et al. Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129 (1945) 585-588
18. Erikssen J., and Rodahl K. Resting heart rate in apparently healthy middle-aged men. Eur J Appl Physiol 42 (1979) 61-69
19. Berenson G.S., Voors A.W., Webber L.S., et al. Racial differences of parameters associated with blood pressure levels in children-the Bogalusa Heart study. Metabolism 28 (1979) 1218-1228
20. Kim J.R., Kiefe C.L., Liu K., et al. Heart rate and subsequent blood pressure in young adults: the CARDIA Study. Hypertension 33 (1999) 640-646
21. Selby J.V., Friedman G.D., and Quensenberry Jr. C.P. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 131 (1990) 1017-1027
22. Mo R., Nordrehaug J., Omvick P., et al. The Bergen blood pressure study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press 4 (1995) 16-22
23. Gillmann M.W., Kannel W.B., Belanger A., et al. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 125 (1993) 1148-1154
24. Thomas F., Guize L., Bean K., et al. Combined effects of pulse pressure and heart rate on cardiovascular mortality. J Hypertens 19 (2001) 863-869
25. Benetos A., Adamopoulos C., Bureau J.M., et al. Determinants of accelerated progression of arterial stiffness in normotensive and treated hypertensive subjects over a 6-year period. Circulation 105 (2002) 1202-1207
26. Palatini P., Casiglia E., Pauletto P., et al. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30 (1997) 1267-1273
27. Fliers E., Kreier F., Voshol P.J., et al. White adipose tissue: getting nervous. J Neuroendocrinol 15 (2003) 1005-1010
28. Grassi G., Dell'Oro R., Facchini A., et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensive. J Hypertens 22 (2004) 2363-2369
29. Pannier B., Thomas F., Eschwège E., et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study. Diabetes Metab 32 (2006) 467-474
30. Grassi G., Dell'Oro R., Quarti-Trevano F., et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48 (2005) 1359-1365
31. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure and why). J Hypertens 19 (2001) 523-528
32. Brunner E.J., Hemingway H., Walker B.R., et al. Adrenocortical, autonomic and inflammatory causes of the metabolic syndrome. Nested case-control study. Circulation 106 (2002) 2659-2665
33. Straznicky N.E., Lambert E.A., Lambert G.W., et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 5998-6005
34. Mancia G., De Backer G., Dominiczak A., et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25 (2007) 1751-1762
35. Palatini P., Benetos A., Grassi G., et al. European Society of Hypertension. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 24 (2006) 603-610